HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
9/10/2024 3:09:51 PM | Chg. -0.600 | Volume | Bid3:09:51 PM | Ask3:09:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.600EUR | -2.59% | - Turnover: - |
22.600Bid Size: - | 22.800Ask Size: - | 5 bill.EUR | - | - |
Assets
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 419.9000 | 443 | 514 | 507 | 969 | ||||||
Intangible Assets | 433 | 447 | 602 | 607 | 1,037 | ||||||
Long-Term Investments | 49.4000 | 56 | 55 | 53 | 55 | ||||||
Fixed Assets | 948.1000 | 1,032 | 1,238 | 1,237 | 2,915 | ||||||
Inventories | 272.3000 | 276 | 273 | 251 | 459 | ||||||
Accounts Receivable | 328.1000 | 439 | 439 | 488 | 759 | ||||||
Cash and Cash Equivalents | 176.5000 | 168 | 280 | 553 | 155 | ||||||
Current Assets | 782 | 897 | 1,013 | 1,360 | 1,448 | ||||||
Total Assets | 1,730.1000 | 1,929 | 2,251 | 2,597 | 4,363 |
Liabilities
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 194.8000 | 241 | 248 | 276 | 343 | ||||||
Long-term debt | 372.5000 | 263 | 145 | 590 | 721 | ||||||
Liabilities to Banks | 565.4000 | 422 | 538 | 705 | 838 | ||||||
Provisions | 33.6000 | 46 | 50 | 49 | 42 | ||||||
Liabilities | 882.3000 | 895 | 1,035 | 1,245 | 1,952 | ||||||
Share Capital | 35.1000 | 35.2000 | 35.2000 | 35.2000 | 40 | ||||||
Total Equity | 832.7000 | 1,017 | 1,197 | 1,337 | 2,396 | ||||||
Minority Interests | 15.2000 | 17 | 19 | 15 | 15 | ||||||
Total liabilities equity | 1,730.1000 | 1,929 | 2,251 | 2,597 | 4,363 |
Income Statement
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,108.7000 | 1,365 | 1,489 | 1,440 | 1,950 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 166.8000 | 352 | 402 | 381 | 302 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 132 | 298 | 362 | 318 | 210 | ||||||
Income Taxes | -24.8000 | -82 | -80 | -64 | -52 | ||||||
Minority Interests Profit | -6.9000 | -4 | -4 | -2 | -3 | ||||||
Net Income | 100.3000 | 212 | 278 | 252 | 155 |
Per Share
Cash Flow
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 182.2000 | 337 | 425 | 366 | 293 | ||||||
Cash Flow from Investing Activities | -101 | -115 | -342 | -162 | -695 | ||||||
Cash Flow from Financing | 6 | -229 | 30 | 77 | 19 | ||||||
Decrease / Increase in Cash | 87.1000 | -7 | 113 | 281 | -383 | ||||||
Employees | 6,649 | 7,067 | 7,139 | 7,189 | 8,339 |